Dehinel 230 mg/20 mg film-coated tablets for cats
Dehinel 230 mg/20 mg film-coated tablets for cats
Authorised
- Pyrantel embonate
- Praziquantel
Product identification
Medicine name:
Dehinel 230 mg/20 mg film-coated tablets for cats
ANTHELMIN COMPRIMES PELLICULES POUR CHATS
Active substance:
- Pyrantel embonate
- Praziquantel
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pyrantel embonate230.00milligram(s)1.00Tablet
-
Praziquantel20.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Withdrawal period by route of administration:
-
Oral use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- (ID3) 10 Film-coated tablet: unspecified outer container with 1 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) with 10 Film-coated tablet, closed with Folie (Aluminium)
- (ID2) 4 Film-coated tablet: unspecified outer container with 2 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) each with 2 Film-coated tablet, closed with Folie (Aluminium)
- (ID1) 2 Film-coated tablet: unspecified outer container with 1 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) with 2 Film-coated tablet, closed with Folie (Aluminium)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- Krka d.d. Novo Mesto
- Tad Pharma GmbH
- Krka-Farma d.o.o.
- Krka-Farma d.o.o.
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/0319717 6/2017
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0160/002
Concerned member states:
-
Cyprus
-
France
-
Greece
-
Italy
-
Poland
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 15/02/2022
French (PDF)
Published on: 6/12/2022
Combined File of all Documents
English (PDF)
Download Published on: 28/07/2023
Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 17/11/2023
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 17/11/2023
How useful was this page?: